Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing

Current Neuropharmacology

Volumn 4, Issue 3, 2006, Pages 225-231

  Palazzo, Enza ^a   de Novellis, V ^a   Marabese, I ^a   Rossi, F ^a   Maione, Sabatino ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cannabinoid receptors; Metabotropic glutamate receptors; Pain; Periaqueductal grey

Indexed keywords

2 CHLORO 5 HYDROXY PHENYLGLYCINE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID; 4 CARBOXY 2 METHYLPHENYLGLYCINE; AMN 082; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CAPSAICIN; CAPSAZEPINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DEXANABINOL; ENDOCANNABINOID; ENZYME INHIBITOR; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; NALOXONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

4 AMINOBUTYRIC ACID RELEASE; ANALGESIA; CHRONIC PAIN; CONCENTRATION RESPONSE; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC TRANSMISSION; HUMAN; HYPERALGESIA; INFLAMMATION; LATENT PERIOD; NERVE CELL STIMULATION; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PERIAQUEDUCTAL GRAY MATTER; RECEPTOR BINDING; REVIEW; SENSITIZATION;

EID: 33747293835     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015906778019545     Document Type: Review

References (104)

1. Akil, H., Young, E., Walker, J.M., Watson, S.J. (1986) The many possible role of opioid and related peptides in stress-induced analgesia. Ann. N.Y. Acad Sci., 467, 140-153.
2. Barbara, J.G., Auclair, N., Roisin, M.P., Otani, S., Valjent, E., Caboche, J., Soubrie, P., Crepel, F. (2003) Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex. Eur. J. Neurosci., 17, 981-990.
3. Behbehani, M.M. (1995) Functional characteristics of the midbrain periaqueductal gray. Prog. Neurobiol., 46, 575-605
4. Behbehani, M.M., Field, H.L. (1979) Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia. Brain Res., 170, 85-93.
5. Bhave, G., Karim, F., Carlton, S.M., Gereau, R.W. (2001) Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat. Neurosci., 4, 417-423.
6. Boxall, S.J., Berthele, A., Laurie, D.J., Sommer, B., Zieglganberger, W., Urban, L., Tolle, T.R. (1998) Enhanced expression of metabotropic glutamate receptor 3 messenger RNA in the rat spinal cord during ultraviolet irradiation induced peripheral inflammation. Neuroscience, 82, 591-602.
7. Bridges, D., Ahmed, K., Rice, A.S. (2001) The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br. J. Pharmacol., 133, 586-594.
8. Budai, D., Larson, A.A. (1998) The involvement of metabotropic glutamate receptors in sensory transmission in dorsal horn of the rat spinal cord. Neuroscience, 83, 571-580.
9. Calignano, A., La Rana, G., Giuffrida, A., Pomelli, D. (1998) Control of pain initiation by endogenous cannabinoids. Nature, 394, 277-281.
10. Carlton, S.M., Hargett, G.L., Coggeshall, R.E. (2001) Localization of metabotropic glutamate receptors2/3 on primary afferent axons in the rat. Neuroscience, 105, 957-969.
11. Cartmell, J., Schoepp, D.D. (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J. Neurochem., 75, 889-907.
12. Catania, M.V., De Socarraz, H., Penney, J.B., Young, A.B. (1994) Metabotropic glutamate receptor heterogeneity in rat brain. Mol. Pharmacol., 45, 626-632.
13. Chen, S.R., Pan, H.L. (2004) Distinct roles of group III metabotropic glutamate receptors in control of nociception and dorsal horn neurons in normal and nerve-injured rats. J. Pharmacol. Exp. Ther., 312, 120-126.
14. Clayton, N., Marshall, F.H., Bountra, C., O'Shaughnessy, C.T. (2002) CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain, 96, 253-260.
15. Costa, B, Colleoni, M., Conti, S., Trovato, A.E., Bianchi, M., Sotgiu, M.L., Piagnoni, G. (2004) Repeated treatment with the synthetic cannabinoid WIN 55, 212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. Br. J. Pharmacol., 141, 4-8.
16. Cristino, M.L. Neuroscience, in press.
17. de Novellis, V., Mariani, L., Palazzo, E., Vita, D., Marabese, I., Scafuro, M., Rossi, F., Maione S. (2005) Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate change in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience, 134, 269-281.
18. Depaulis, A., Bandler, R. (1991) The midbrain periaqueductal grey matter- functional, anatomical and neurochemical organization. Plenum Press, New York, 67.
19. De Petrocellis, L., Cascio, M.G., Di Marzo, V. (2004) Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. Br. J. Pharmacol., 141, 3251-3256.
20. Dolan, S., Nolan, A.M. (2000) Behavioural evidence supporting a differential role for group I and II metabotropic glutamate receptors in spinal nociceptive transmission. Neuropharmacology, 37, 1132-1138.
21. Egertova, M., Giang, D.K., cravat, B.F., Elphick, M.R. (1998) A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc. Biol. Sci., 265, 2081-2085.
22. Evans, D.I., Jones, G., Woodhall, G. (2000) Activation of presynaptic group III metabotropic receptors enhances glutamate release in rat entorhinal cortex. J. Neurophysiol., 83, 2519-2525.
23. Field, H.L., Basbaum, A.I. (1994) Central nervous system mechanisms of pain modulation. Churchill Livingstone, Edimburgh, UK.
24. Fields, H.L., Bry, J., Hentall, I., Zorman, G. (1983) The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J. Neurosci,. 3, 545 -552.
25. Fields, H.L., Heinricher, M.M., Mason, P. (1991) Neurotransmitters in nociceptive modulatory circuits. Ann. Rev. Neurosci., 14, 219-245.
26. Finn, D.P., Jhaveri, M.D., Bekett, S.R.G., Kendall, D.A., Marsden, C.A., Chapmann, V. (2002) The role of the periaqueductal grey in cannabinoid-mediated antinociception. J. Psychopharmacol., 16, A57
27. Finn, D.P., Jhaveri, M.D., Bekett, S.R.G., Roe, C.H., Kendall, D.A., Marsden, C.A., Chapmann, V. (2003) Effect of direct periaqueductal grey administration a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology, 45, 594-604.
28. 1 receptors in the anti-hyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 92, 91-100.
29. Fundytus, M.E. (2001) Glutamate receptors and nociception. Implications for the drug treatment of pain. CNS Drugs, 15, 29-58.
30. Ghauri, M., Chapman, A.G., Meldrum, B.S. (1996) Convulsant and anticonvulsant actions of agonist and antagonist of group III mGluRs. Neuroreport, 7, 1469-1474.
31. Hama, A.T. (2003) Acute activation of the spinal cord metabotropic glutamate subtype-5 receptor leads to cold hypersensitivity in the rat. Neuropharmacology, 44, 423-430.
32. Han, J.S., Bird, G.C., Neugebauer, V. (2004) Enhanced group III mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala. Neuropharmacology, 46, 918-926.
33. Han, J.S., Neugebauer, V. (2005) mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain, Pain, 113, 211-222.
34. Herkenham, M., Lynn, A., Johnson, M.R., Melvin, L.S., De Costa, B.R., Rice, K.C. (1991) Characterization ad localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci., 11, 563-583.
35. Herzberg, U., Eliav, E., Bennett, G.J., Kopin, I.J. (1997) The analgesic effect of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett., 221,157-160.
36. Hohmann, A.G. (2002) Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chem. Phys. Lipids., 121, 173-190.
37. Hohmann, A.G., Suplita, R.L., Bolton, N.M., Neely, N.H., Fegley, D., Mangieri, R., Krey, J.F., Walker, J.M., Holmes, P.V., Crystal, J.D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Piomelli, D. (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature Lett., 435, 1108-1112.
38. Hohmann, A.G., Tsou, K., Walker, J.M. (1998) Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN 55,212-2. Neurosci. Lett., 257, 119-122.
39. Hu, H.G., Bhave, G., Gerau, R.W. (2002) Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia. J. Neurosci., 22, 7444-7452.
40. Hudson, L.J., Bevan, S., McNair, K., Gentry, C., Fox, A., Kuhn, R., Winter. J. (2002) Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia. J. Neurosci., 22, 2660-2668.
41. Iversen, L., Chapman, V. (2002) Cannabinoids: a real prospect for pain relief? Curr. Opin. Pharmacol., 2, 50-55.
42. Karim, F., Wang, C-C, Gereau, R.W. (2001) Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J. Neurosci., 21, 3771-3779.
43. La Rana, G., Russo, R., Campolongo, P., Bortolato, M, Manieri, R.A., Cuomo, V., Iacono, A., Mattace Raso, G., Meli, R., Pionielli, D., Malignano, A. (2006) Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404. J. Pharmacol. Exp. Ther., (in press).
44. Lee, B.H., Park, S.H., Won, R., Park, Y.G., Sohn, J.H. (2000) Antiallodynic effects produced by stimulation of the periaqueductal gray matter in a rat model of neuropathic pain. Neurosci. Lett., 291, 29-36.
45. Levine, J.D., Murphy, D.T., Seidenwurm, D., Cortez, A., Fields, H.L. (1980). A study of the quantal (all or none) change in reflex latency produced by opiate analgesics. Brain Res., 201, 129-141.
46. Leyva, J., Maione, S., Pallotta, M., Berrino, L., Rossi, F. (1995) Metabotropic and ionotropic glutamate receptors mediate opposite effects on periaqueductal gray matter. Eur. J. Pharmacol., 285, 123-126.
47. Li, J., Daughters, R.S. Bullis, C., Bengiamin, R., Stucky, M.W., Brennan, J., Simone, D.A. (1999) The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats. Pain, 81, 25-33.
48. Li, W., Neugebauer, V. (2004) Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons. J. Neurophysiol., 91, 13-24.
49. Lichtman, A.H., Cook, S.A., Martin, B.R. (1996) Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal grey involvement. J. Pharmacol. Exp. Ther., 276, 585-593.
50. Lichtman, A.H., Martin B.R. (1991) Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther., 258, 517-523.
51. Lim, G., Sung, B., Ji, R.R., Mao, J. (2003) Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of WIN 55,212-2 on neuropathic pain behaviours in rats. Pain, 105, 275-283.
52. Maione, S., Bisogno, T., de novellis, V., Palazzo, E., Cristino, L., Valenti, M., Petrosino, S., Gugliemotti, V., Rossi, F., Di Marzo, V. (2005) Elevation of endocannabinoid levels in the ventrolaterl periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both CB1 and TRPV1 receptors. J. Pharmacol. Exp. Ther., 316, 969-982.
53. Maione, S., Marabese, I., Leyva, J., Palazzo, E., de Novellis, V., Rossi, F. (1998) Characterisation of mGluRs which modulate nociception in the PAG of the mouse. Neuropharmacology, 37, 1475-1483.
54. Maione, S., Oliva, P., Marabese, I., Palazzo, E., Rossi, F., Berrino, L., Rossi, F., Filippelli, A. (2000) Periaqueductal gray matter metabotropic glutamate receptors modulate formalin-induced nociception. Pain, 85, 183-189.
55. Mailleux, P., Vanderhaeghen, J.J. (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience, 48, 655-668.
56. Malan, T.P., Ibrahim, M.M., Deng, H., Liu,. Q., Mata, H.P., Vanderah, T., Porreca, F., Makriyannis, A. (2002) CB2 cannabinoid receptor-mediated peripheral antinociception. Pain, 93, 239-245.
57. Manning, B.H. (1998) A lateralized deficit in morphine antinociception after unilateral inactivation of the central amygdala. J. Neurosci., 18, 9453-9470.
58. Marabese, I., de Novellis, V., Palazzo, E., Mariani, L., Siniscalco, D., Rodella, L., Rossi, F., Maione, S. (2005) Differential roles of mGlu8 receptors in the regulation of glutamate and γ-aminobutyric acid release at periaqueductal grey level. Neurapharmacology, 49, 157-166.
59. Marabese, I., de Novellis, V., Palazzo, E., Scafuro, M.A., Vita, D., Rossi, F., Maione, S. (2006) Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice. Neuropharmacolgy, in press.
60. Marsicano, G., Goodenough, S., Monory, K., Hermann, H:, Eder, M., Cannich, A., Azad, S.C., Cascio, M.G., Gutierrez, S.O., van der Stelt, M., Lopez-Rodriguez, M.L., Casanova, E., Schuz, G., Zieglagansberger, W., Di Marzo, V., Behl, C., Lutz, B. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science, 302, 84-88.
61. Martin, W.J., Coffin, P.O., Attias, E., Balinsky, M., Tsou, K., Walzer, J.M. (1999) Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res., 822, 237-242.
62. Martin W.J., Hohmann, A.G., Walker, J.M. (1996) Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electophysiological and antinociceptive effects. J. Neurosci., 16, 6601-6611.
63. Martin, W.J., Loo, C.M., Basbaum, A.I. (1999) Spinal cannabinoids are antiallodynic in rats with persistent inflammation. Pain, 82, 199-205.
64. Martin, W.J., Tsou, K., Walker, J.M. (1998) Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci. Lett., 242, 33-36.
65. Meng, I.D., Johansen, J.P. (2004) Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptors agonist. Neuroscience, 124, 685-693.
66. Monhemius, R., Green, D.L., Roberts, M.H., Azami, J. (2001) Periaqueductal grey mediated inhibition of responses to noxious stimulation is dynamically activated in a rat model of neuropathic pain. Neurosci. Lett., 298, 70-74.
67. Neugebauer, V. (2001a) Metabotropic glutamate receptor: novel target for pain relief. Expert Rev. Neurother., 1, 207-224.
68. Neugebauer, V. (2001b) Peripheral metabotropic glutamate receptors: fight the pain where it hurts. Trends Neurosci., 24, 550-552.
69. Neugebauer, V., Chen, P.S., Willis, W.D. (1999) Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells. J. Neurophysiol., 82, 272-282.
70. Neugebauer, V., Chen, P.S., Willis, W.D. (2000) Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate STT cells. J. Neurophysiol., 84, 2998-08.
71. Palazzo, E., de Novellis, V., Marabese, I., Cuomo, D., Rossi, F., Berrino, L., Rossi, F., Maione, S. (2002) Interaction between vanilloid and glutamate receptors in the central modulation of nociception. Eur. J. Pharmacol., 439, 69-75.
72. Palazzo, E., Genovese, R., Mariani, L., Siniscalco, D., Marabese, I., de Novellis, V., Rossi, F., Maione, S. (2004) Metabotropic glutamate receptor 5 and dorsal raphe serotonin release in inflammatory pain in rat. Eur. J. Pharmacol., 25, 169-176.
73. Palazzo, E., Marabese, I., de Novellis, V., Oliva, P., Rossi, F., Berrino, L., Rossi, F., Maione, S. (2001) Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Neuropharmacology, 40, 319-326.
74. Pertovaara, A., Kontinen, V.K., Kalso, E.A. (1997) Chronic spinal nerve ligation induces changes in response characteristics of nociceptive spinal dorsal horn neurons and in their descending regulation originating in the periaqueductal gray in the rat. Exp. Neurol., 147, 428-436.
75. Pertwee, R.G.(2001) Cannabinoid receptors and pain. Prog. Neurobiol., 63, 569-611.
76. Piomelli, D., Beltramo, M., Giuffida, A., Stella. M. (1998) Endogenous cannabinoid signalling. Neurobiol. Dis., 5, 462-473.
77. Prieto, G.J., Cannon, J.T., Liebskind, J.C. (1983) Nucleus raphe magnus lesions disrupt stimulation-produced analgesia from ventral but not dorsal midbrain areas in the rat. Brain Res., 226, 53-57.
78. Reynolds, D.V. (1969) Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science, 164, 444-445.
79. Rice, A.S.C., Farquhar-Smith, W.P., Nagy, I. (2002) Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot. Essent. Fatty Acids, 66, 243-256
80. Richardson, J.D., Aanonsen L., Hargreaves, K.M. (1998) Antihyperalgesic effects of spinal cannabinoids. Eur. J. Pharmacol., 345, 145-153.
81. Richardson, J.D., Kilo, S., Hargreaves, K.M. (1998) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain, 75, 111-119.
82. Rinaldi-Carmona, M., Barth, F., Heaulme M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie P., Breliere, J.C., LeFur, G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
83. Salt, T.E., Binns, K.E. (2000) Contributions of mGlu1 and mGlu5 receptors to interactions with N-methyl-D-aspartate receptor- mediated responses and nociceptive sensory responses of rat thalamic neurons. Neuroscience, 100, 375-380.
84. Salt, T.E., Eaton, S.A., Turner, J.P. (1996) Characterization of the metabotropic glutamate receptors (mGluRs) which modulate GABA-mediated inhibition in the ventrobasal thalamus. Neurochem. Int., 29, 317-322.
85. Salt, T.E., Turner, J.P. (1998) Reduction of sensory and metabotropic glutamate receptor responses in the thalamus by the novel metabotropic glutamate receptor-1-selective antagonist S-2-methyl-4-carboxy-phenylglycine. Neuroscience, 85, 655-668.
86. Sasamura, T., Sasaki, M., Tohda, C., Kuraishi, Y. (1998) Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus. Neuroreport, 9, 2045-2048.
87. Scott, D.A., Wright, C.E., Angus, J.A. (2004) Evidence that CB1 and CB2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat. Pain, 109, 124-131.
88. Smith, F.L., Cichewicz, D., Martin, Z.L., Welch, S.P. (1998) The enhancement of morphine antinociception in mice by D-9-tetrahydrocannabinoil. Pharmacol. Biochem. Behav., 60, 559-566.
89. Sofia, R.D., Nalepa, S.D., Harakel, J.J., Vassar, H.B. (1973) Anti-edema and analgesic property of delta-9-tetrahydrocannabinol (THC). J. Pharmacol. Exp. ther., 186, 646-655.
90. Stanfa, L.C., Dickenson, A.H. (1998) Inflammation alters the effect of mGlu receptor agonists on spinal nociceptive neurons. Eur. J. Pharmacol., 347, 165-72.
91. Tang, E., Yip, P.K., Chapman, A.G., Jane, D.E., Meldrum, B. S. (1997) Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats. Eur. J. Pharmacol., 327, 109-115.
92. Tsou, K., Brown, S., Sanudo-Pena, M.C., Mackie, K., Walker, J.M. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393-411.
93. Valtschanoff, J.G., Rustioni, A., Guo, A., Hwang, S.J. (2001) Vanilloid receptor VR1 is both presynaptic and postsynaptic, in the superficial laminae of the rat dorsal horn. J. Comp. Neurol., 436, 225-235.
94. Van Sickle, M.D., Duncan, M., Kingsley, P.J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J.S., Marnett, L.J., Di Marzo, V., Pittman, Q.J., Patel, K.D., Sharkey, K.A. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 310, 329-332.
95. Vaughan, C.W., Connor, M., Bagley, E.E., Christie, M.J. (2000) Action of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal grey neurons in vitro. Mol. Pharm., 57, 288-295.
96. Walker, J.M., Huang, S.M. (2002) Endocannabinoids in pain modulation. Prostaglandins Leukot. Essent. Fatty Acids, 66, 235-242.
97. Walker, J.M., Huang, S.M., Strangman, N.M., Tsou, K., Sanudo-Pena, M.C. (1999) Pain modulation by release of the endogenous cannabinoid anandamide. Proc. Natl. Acad. Sci. USA, 96, 12198-12203.
98. Walker, K., Reeve, A., Bowes, M., Winter, J., Wotherspoon, G., Davis, A., Schmid, P., Gasparini, F., Kuhn, R., Urban, L.(2001) mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology, 40, 10-19.
99. Welch, S.P., Thomas, C., Patrick, G.S. (1995). Modulation of cannabinoid-induced antinociception,following intracerebroventricular versus intrathecal administration to mice: Possible mechanisms for interaction with morphine. J. Pharmacol, Exp. Ther., 272, 310-321.
100. Young, M.R., Fleetwood-Walker, S.M., Dickinson, T., Blackburn-Murno, G., Sparrow, H., Birch, P.J., Bountra, C. (1997) Behavioural and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cord. Brain Res., 777, 161-169.
101. Young, M.R., Blackburn-Murno, G., Dickinson, T., Johnson, M.J., Anderson, H., Nakalembe, Fleetwood-Walker, S.M. (1998) Antisense ablation of type I metabotropic glutamate receptor mGluR1 inhibits spinal nociceptive transmission. J. Neurosci., 23, 10180-10188.
102. Young, M.R., Fleetwood-Walker, M., Mitchell, R., Dickinson, T. (1995) The involvement of metabotropic glutamate receptors and their intracellular signalling pathways in sustained nociceptive transmission 'in rat dorsal horn neurons Neuropharmacology, 34, 1033-1041.
103. Young, M.R., Fleetwood-Walker, M., Mitchell, R., Munro, F.E. (1994) Evidence for a role of metabotropic glutamate receptors in sustained nociceptive inputs to rat dorsal horn neurons. Neuropharmacology, 33, 141-144.
104. Zhou, S., Komak, S., Do, J., Carlton, S.M. (2001) Metabotropic glutamate lα receptors on peripheral primary afferent fibres: their role in nociception. Brain Res., 913, 18-26.